Reference sequence (query): batch____ Identities normalised by aligned length. Colored by: property
HSP processing: ranked Search cycle: 3
1 [ . . . . : . . . . 1 . . . . : ] 153
batch____ bits E-value N 100.0% 1:153 MIKSWWAEKSTSEKQIVAALAVLSLGVFCWLGVIKPIDTYIAEHQSHAQKIKKDIKWMQDQASTHGLLGHPALTQPIKNILLEEAKRENLAITLENGPDNTLTIHPVTAPLENVSRWLTTAQVTYGIVIEDLQFTLAGNEEITLRHLSFREQQ
1 UniRef50_Q47VE3 General secretion pathway p... 126 2e-28 1 17.9% 2:146 1:149 -MKEWWQQLNSREQRLVAVMALVFIIFIFYSAIWQPINNSLTEANNKLAKQQELLTWVEENTALyrSGGKSKLSGSISSVANRSAKTYKLTITRMQPQGDDLQVWIDSTPFTQLLFWLEHLANNEGLQVKAIDLTRGDSAGEVKVR-------
2 UniRef50_Q7MPY7 Type II secretory pathway, ... 120 2e-26 1 19.9% 1:146 7:156 MFQAWWSSISQREQRLVVVCGVFGLIGLIYWGVLQPINARAEQAQLRIQSEKQLLSWVSEKADELTGLRASgsNQPLNQVIASSARQFKVELQRVQPRNEMLQVWVAPMPFNRLVDWLTFLKEKQGIEVEFMDIDRGKESGLVEVN-------
3 UniRef50_Q089T8 General secretion pathway M... 118 6e-26 1 13.8% 2:153 4:158 -MRSWWQGLAIREQQLVGFCAAVLAIGIMYWGIWTPISNAQDTAERDNSAAQQTLNYVKQTANKIAGLKQAGAqgSLSSVVNQTAGQYKLEITRMQPQGDKIQLWMDDVPFDALLGYLHDLVEQKGLTLDSVDLTESDVAGFVKVR-RIQLSQ
4 UniRef50_D0M419 General secretion pathway p... 113 2e-24 1 18.1% 3:146 9:156 --QAWWSSISQREQRLVMGCGAIAVIGIIYWGLLQPMSQRAELAQSRIQSEKQLLAWVQDKADGITALRKSssSQPLNQLVSSSARRYKVELIRVQPRNESVQVWIKPLAFNQLVDWLRYLKEQQGIEVEFLDIDRTDQAGMIDVN-------
5 UniRef50_Q21EQ3 General secretion pathway M... 113 2e-24 1 11.9% 2:152 7:161 -FKEWWGNASSRDQISLVVCSVCVALYILFMGVLSPLYDMRDAQVRSHESAVVTLARVKELAAQIKGSggRSGGPSIVDLVDSSLRSHGLRLSNMQPSgsDVRLRLDEVSFNSLLAWLNEMEVEKGLQVKDMSIAESSNIGMVSVTLRLHQE-
6 UniRef50_C8UAZ7 Type II secretion protein E... 112 4e-24 1 12.8% 2:149 4:156 -LKKRLQYISPRERRLLTGCVALLVVAFVYYVFWLPWQVREDKWRTVIAREKYTVEWMKQQIPSIKKWEASMPEqgLSAAVTQTSAAYGVSVTRLQPQGERLTVTLAPVEFNTLMQWLTQLHRRYRIRTVVFDVVAQGnpGHVTVNRLV----
7 UniRef50_P41851 General secretion pathway p... 111 7e-24 1 14.5% 2:146 8:157 -VQAWWRSVTPREQKMVMGMGALTVLAIAYWGIWQPLSERTAQAQARLQTEKQLLSWVSENANDIVTLRaaPSDQPLNQVITNSTRQFNIELIRVQPRGEMMQVWIQPLPFSQLVSWIAYLQERQGVSVDAIDIDRGKVNGVVEVK-------
8 UniRef50_B8GU53 General secretion pathway M... 106 3e-22 1 13.4% 2:150 1:157 -MKAWWEGLNQRDRRILMVGGALLCLLLPYMLIWQPLHDRAERLERTLVAQRADVSWmqLRATAATGRTPTPAGQSLLGMIDRTVrqLGGTVRRVQPEgnTVRVWLEDAPFDELMTWLGTLETRHGIRATSLVVDRQATPGRVNARLTLE---
9 UniRef50_Q2SFC5 Type II secretory pathway, ... 105 4e-22 1 13.0% 4:149 18:172 ---TWFYGLSQRDQTALKWMALVVAAFSVYMFVWAPVQDFVESSKNSAEASHESLTWMKENEARARASSRqsGGQSLLSTVGSSARKFGLELQRFEPRgdKVNVWLDKVSFNQLMLWLGELEKNYGVAVEQITVDKADAPGVVSSRLSL----
10 UniRef50_A6FGY6 General secretion pathway p... 105 6e-22 1 17.2% 2:146 1:149 -MKAYWQQLEQKEKQLISILIVTLVLACGYWLLWQPLQHDIINTQRKVNVQTQTLADvqKIMDLQGGKGKRSEAGDLNQLVSRSAARNQIVITRIQAKSDTLQIWIDDVNFNQFTAWLERLNKQYGIEIQNIDLSVSDAKGMVKVR-------
11 UniRef50_P41850 General secretion pathway p... 104 1e-21 1 16.6% 2:146 5:155 -LQGWWRSISAREQRLVAVGGSCLLIGFCYWIVWQPIANRIAERERQVLSQQQTLAWLKEkaMQGGQGRQIDTSGTLEGVVNRTAFNQKIKIARLQPQGQELQVWIDTVQFDDLLIWLASLADQHGVQVQVIEVAREnaPGLVKVR-------
12 UniRef50_A0YBF1 Type II secretory pathway, ... 103 1e-21 1 15.4% 2:150 14:167 -FSVRYESLENRDRLAIKLLLGFIVTVIIIFGMILPASNYKASSEAYYRNSLETLTWMQGNKPLiqRRLVRDSGQSLLGIANKTSKGFNLTFKRYQPVGegLSLWLENESFNNVILWLERLDKRHGISVDEISVDRDEQDGLVSIRLVLQ---
13 UniRef50_C5BM29 General secretion pathway p... 103 1e-21 1 14.6% 2:152 4:159 -LKEWWNKASTRDQLSLAIGGGILLLYLCYMVLLKPVTEMRDNQLHRNMAQAEALERVRELAATWVNREgsDNGRSLVDVVNSSLQQNSLRMTGMQPSgnDVRLRLEQVPFDNLLAWLYDIEVSQRLQVKDISVATGSNEGLVSVNIRLHRE-
14 UniRef50_D0I3A1 General secretion pathway p... 103 2e-21 1 14.5% 2:146 4:154 -LIAYWQGLSRREQRLLGVASAVILLGTLYWGVVSPLQAKAEQAEQRLASERNLLSWVNSKAAEIEALRRAtsALPLNQSVTTTVKRYNLEIVRLQPQQEEIQVWLKPMPFNALISWLDDLSVNHGVQVKFIDVGKTETLGVVDVK-------
15 UniRef50_C4K3F9 Putative uncharacterized pr... 102 3e-21 1 15.2% 2:146 1:151 -MKQRWHHLSLRERYFLIGGVFCLLTFLSYSLVWQPLQKKILLAQKKLEQHRQLLHQIHLAKPALKEWLNRrpDESLSNIVHQSAAQAGMEIIKMQEEEKALRVWIAEVSFKKLVSWLFDLQYRHGIQTAYLDLVETGIPGIVEVQ-------
16 UniRef50_Q1ZIZ1 Type II secretory pathway, ... 102 3e-21 1 19.7% 3:149 6:157 --RIWWATSNIKERRLVVVIVLFLAFSLCYWGAWKPLSTRLDNSEIQLLRTQKTLSWVQEKASLlgSQVAQVPQSSLVEVINRSAKRSGISFTRILNRNDTLEVWIADVEFNNTMDWLTLLKNKYGIEVLNVDINQALKPGYIKINRLV----
17 UniRef50_C6XJ56 General secretion pathway M... 102 5e-21 1 14.1% 1:149 1:153 MIKNWWAAREPREKLLLSICLVLTLTIVLFQFIFGPSVEFRDRASKRYLSQASSHSEVVQTLRVYENSPraVSAGPVQGVVSDSSAVFGIDISRIEPTSNglTLWIEEIDPQSLYAWLTDLEINHGISVNKASIRMNKDTVTVNANVLV----
18 UniRef50_A8AIM9 Putative uncharacterized pr... 101 8e-21 1 18.9% 2:149 8:155 -LKARYQNYSDRERGLITLCAAAMCCAVIYYGGIIPLDHMIQNSQSTLMRQKETLRWMRDEIDKNHLQAKVLKTNNPRTVIEESAKEIHLALSDIRQDERSLSFVVEQVNIYELKNWLREVNVTSGVQLQKMDLRPVDRQSDVKANITL----
19 UniRef50_UPI0000E10E09 general secretion pathway p... 101 9e-21 1 12.4% 2:146 6:154 -LSDWFSQLAPREQALLKVGSVILIIAGFYGLVWAPMNASIERETKLLAQQQALSTWVVQQQAKVLQFRRQGPggSLVQAVNQTARASNITLTRMQPNNDEVQVWIDEVGFNTLMTWLGSLDTT-GVRVLQVDITEAGAPGNVKVR-------
20 UniRef50_Q46832 Putative general secretion ... 100 2e-20 1 13.1% 2:146 25:171 -LAQHLAGRSPREKGMLLAAVVFLFSVGYYVLIWQPLSERIEQQETILQQLVAMNTRLKNAAPDIIAARKSATTTpvSRVISDSASAHSVVIRRIADRGENIQVWIEPVVFNDLLKWLNALDEKYALRVTQIDVSAAEKPGMVNVQ-------
21 UniRef50_P31709 General secretion pathway p... 100 3e-20 1 15.2% 2:146 4:154 -LRQRWQAMSQRERQLMVVCAAVLLLCVVYYAILQPWQEREDLWERTISREQQTVNWMQKQASSIPRGNQAQgdVSLPILISQSTKRYGLTVVRLQPQGSQASVTLGQSDFNSLLRWLGELEQKNGVKVISLDVNAVEqpGIVDVT-------
22 UniRef50_A3SDU2 General secretion pathway p... 99 6e-20 1 14.2% 6:153 4:151 -----FAALNPRERRLVGIVLPLAIVVVGYQFLWAPLHRAQAEARADIQAFRLVQDTAALASVDTIVSLQPLNETPLATRITTSASAANLTLRRIEPENDSIRVTLDDTPFATILLWLSDLEEQHDVRVEALEVDRRPAPGRVSARLLLGSLQ
23 UniRef50_A4BDW7 General secretion pathway p... 98 8e-20 1 16.2% 2:149 9:158 -LREKWLSLSRRDQQAARLLGISLLIAIIVFGLIVPLASWRQDLQRELANAQQTLQELTALAPQAMAVTGGATELNPssEIRRQAARYGIEIQRFEPDGELLRVWLDDARYPSVVQWLGGLE-NMGIGHTELALDDRPNPGFVNVRVTF----
24 UniRef50_A5ID27 Putative general secretion ... 97 1e-19 1 14.2% 2:149 1:153 -MKTYLNTLNDREKWMVIVAGVSLFIYGYYLLLYAPLSNQVNQKSTQLIEKTETLEWMK-QVRMQKRSAKRKESVDNSQLLTILASqlKFPYQLQQTGSGDVQLTFDEVPFQNFIQWLAKINEVYSINIKQFDVEKTPTPGVTRLMIIL----
25 UniRef50_A3MPL1 General secretion pathway p... 97 1e-19 1 12.8% 2:150 17:170 -LSQFWEARTAREKLLLGWGGAVLALAIAYSVLWSPAQEGRARIQRELPTMRHELAEMTAQANEARTLAGAAqgVALKDALAASLSDHGLAAAAPQVVGGGVQIQLKNASFPAWTQWLDDVRRQFKAQVVEAHVSALKEDGQVDLTAVLQ---
26 UniRef50_Q3ILM0 Putative general secretion ... 97 2e-19 1 14.9% 2:149 5:154 -LIKHWRSLKEQEQQLIIVASGIFIVFILVMGIFRPLNNAIASAEQSQLKQQELLVWVDESIVKLKAAGNTqnSQNISQIVNATRGRYKINISKMQPSNNSLRLTLDSVEFNQLILWLDELVNQHGLRVENLDLSRDDKSGYVRVSRLL----
27 UniRef50_A0YG42 Type II secretory pathway, ... 97 2e-19 1 13.9% 2:152 1:158 -MQHWFYSLKRQEQIVLLFGIVVVFSYLLYVVVLRPLSAAVERLEQKNEVASRSLNVVEALSKEYQSLKKKSGsqNLTRLIDTTVKNNTLTMTRFQPSSSgvQVRFENAVFDNILSGLHELEVGNGIVIKDLSVTNGSATGLVNVSVRLRQE-
28 UniRef50_Q15ZB6 General secretion pathway M... 96 3e-19 1 19.3% 2:146 4:152 -LKQKFSQLTEREQRLVLISAVVVVVGMFYWLVWSPLNQAIERDQKALDSQKSLLSWVQKSANRAIQLRAAKgnGSLAQAANQTAANANIPIARMQPQGDELQVWVDQAPFNGVLDWLKSLEE-MGVSILDLDIAEADAPGQVKIR-------
29 UniRef50_A1WZN8 General secretion pathway M... 96 4e-19 1 13.6% 5:151 16:172 ----FWSARNPRERWLLGSGGLLVLVVVPYVAVWEPLTERRDQLQAQVAEQRQDLAWMRSAAEEigSAEPVTDERSLLSLVDRAAREAGIDDqrVQPDGDglRVWMDRVPFDELMNWLDGLQRAAGVEVDALTVERTQEDGLVNVRLTLEV--
30 UniRef50_Q1N4H7 Type II secretory pathway, ... 95 8e-19 1 14.0% 2:151 25:176 -VHNWYSQLGTNDQSIVKVLLFVISLVLIYAWIWQPAVDARDAANKSFNKELSFHESLKENAYRFksSSNQPSGGSILSIVSATAKAKKIELRRFEPDgtRLRIWLDKAEFDAVIDWIEILEAEKGILVEQISLDKVS-SGRVNVRAVLTQ--
31 UniRef50_P36678 Putative general secretion ... 95 8e-19 1 100.0% 1:153 1:153 MIKSWWAEKSTSEKQIVAALAVLSLGVFCWLGVIKPIDTYIAEHQSHAQKIKKDIKWMQDQASTHGLLGHPALTQPIKNILLEEAKRENLAITLENGPDNTLTIHPVTAPLENVSRWLTTAQVTYGIVIEDLQFTLAGNEEITLRHLSFREQQ
32 UniRef50_D2TMG9 Putative T2SS protein M n=1... 95 8e-19 1 25.5% 2:150 5:155 -IREWLQQKNPTEQRIVIALFILCVATIYGCGLWLPLNHTVDALQTRCNKLRQDMAWLEKQAQARGVLPQRTPEEPVASLLKKEAEQAGFSVTLTQNSADGVEISANDISQQAFTAWLTRLQSRHGLYVETLEfsPAKADAITLSKMTVR---
33 UniRef50_D1RFN4 Type II secretory pathway p... 94 1e-18 1 12.3% 2:147 1:151 -MKSYLSTLNEREKWMLIGTGLCLILYIYYLFLYTPLNNRVNQKSTQLVDKINTLQWMK-KIKQQGRTTQTKQVVSNSQLLTALATqlKFPYQLQQTGSGDIQLTFDAVAFNLFIAWLEKINQGYAITVKQFEADRTKTPGITRLMI------
34 UniRef50_O32575 W0031 n=14 Tax=Escherichia ... 94 2e-18 1 12.8% 2:149 4:156 -LKKRLQYVSPRERRLLIGCVALLVVVFVYYVLWQPWLIREDKWRTVVTREKNTVEWMKQQVPNIKRREASMPEQglSAAVTRTSAAYGVSVTRLQPQGERLAVTLAPVEFNALMQWLTQLERRHRIRTMVFDVAAQGnpGQVTVNRLV----
35 UniRef50_B3PEM1 General secretion pathway p... 93 3e-18 1 12.0% 4:153 6:160 ---AFLNRYQRREQIALLALGIAVVIFLLWILILAPLQKKREQLQTANTAATQTLGKVRIMAAQIQQArqARSGENISGLIDSSLRGNGLTMSGFQPgaGEVRVRLDRAAYEPLMQWLYELEFKHGVSVRDLSLAATNDPGLVTVNLRLQKAQ
36 UniRef50_D0XKE5 General secretion pathway M... 93 3e-18 1 13.6% 4:150 19:162 ---AWYAGRSRREQVLLAVLGGFLTVAVLWLGILQPLLDARATAIGRIAAYETVMVRVRTAGP--VGATAAGLSGPLETAIPAQAATFGIIPASVTPDGDAATVTVTEARYDSVVPWLAGLEAS-GATLSSVRIDRGSQPGVVNVSVRVQ---
37 UniRef50_Q0A613 General secretion pathway M... 92 5e-18 1 13.2% 2:152 5:163 -LLAHWQGLEPRERRILLAGALVLAVLLPWGGIWLPLSDRAETLRGEVAEARAQQAWMAAAAERVRQAGGATaaDSLLGRVDRSAGDYGlrLERLQPDGdrVRVWLERADFDQMLYWLDALAET-GVRVHALSLEPLDAPGRVNARLTLESE-
38 UniRef50_P15752 General secretion pathway p... 91 1e-17 1 14.6% 6:149 8:154 -----WQQRTRRERCLLLGMAVVLLIGLVYYTLWQPWQNREAQWRQTLAREQASLQWMRQQTPLIRQLRNQKppEEPSTVIMREAARHGLTIVRLQPQGSRLSLTVQPADFQALMAWLDALGQAGMTTATLAVTAVAQQPGWVTVNTLV----
39 UniRef50_A4A5K6 General secretion pathway p... 89 3e-17 1 16.9% 2:149 1:155 -MKDWFERYTLREQLALLAMALVVTLYLLGVFVIQPLGQARADLAARNTATAEALLRVDAMATEIRALerGTRSANLSASLNQSAGRYALRVSRLQPNSQgvQLRFESAPLDALLRWIHELETTQGLRVDDLSLSQTSTAGTVSATLRV----
40 UniRef50_Q3BXL7 Type II secretion system pr... 89 4e-17 1 11.4% 5:144 11:150 ----WWQTRAPRERRMLGVMCAALAAFVGWYALYMPLRHWHDRAWARYADAAQLVLDASAQAASTRHTAAPGPA-ALAKIIASSARDAGVNITSQQRsaGGVEVQIEAVSAATLFGWLKRLRQAHGLAPTQLHVAREQGQLRVR---------
41 UniRef50_B5JVC5 General secretion pathway p... 89 6e-17 1 12.0% 4:153 2:158 ---EWWHRYSQREQRTLLAGGAVLAVFLIYMLLLEPLVDFHQQGKADLETHRELHQWMAQAVAEYRSIGGsaSSGSVAVAVENALKQSGLpaTRIAPKGqaVSVSYDSVAFDRLMHTLDKLTLDQGLQLAQFQASAVGDERKGMASVEFELER
42 UniRef50_Q0VPY0 General secretion pathway p... 88 9e-17 1 15.6% 4:150 20:171 ---QWYESREPREQHILKILAVVAFVVLLYWLLWAPSVAARDQAKKQFMVNQQTLQWIQDNREAVIAARRSdpNGNWTGNVSRSADQFGLTLKGFSPDGNrvRIQMENQATSQTVLWLQSLQQS-GIQISNLEMTPGEKSGTATVRATLQ---
43 UniRef50_Q1NDR5 Putative uncharacterized pr... 88 1e-16 1 13.6% 5:151 7:157 ----YWAERSPRERWMLGVMFALLAIVILWFGIAVPLDRAQRDARDRLVEATERNAAIRATVAQLKALPRAPAnvPLDQFVGQSAGEAGLTLERAQAQgdRMDIAIASVRPIALFSWLSTLE-GQGVRVVTMSARPSPTAGSISVQAVLER--
44 UniRef50_B7RST8 General secretion pathway p... 87 1e-16 1 11.5% 2:149 1:153 -MKQWFTGLTQREQLSLLIMGLAVALYLAFVIVIAPLSQARDRMVVQNRGVAESLQRVEVLVSQILHLrgSSTNRNLASLVNRSTSSYQLQVNRLQPNsgELQVRLENAVFDDLIAWLYQVEYKEGLRVLETSITQAGTVGRVNATVRL----
45 UniRef50_A1SR65 General secretion pathway M... 87 1e-16 1 12.4% 2:146 5:154 -LNTWWESITEREQQLSLVSVLLILIAIIYWGIWQPLSIGLDNSENQLQRAQQTLSTTQQRATLLVSAgaVSENQNVTQIVTISAQQNGITFSRIINRNEQVEVQVSNVEFDRFINWVSVLSSQYSVSVLNADISRADEEGYIKVT-------
46 UniRef50_B7RHZ7 Putative uncharacterized pr... 87 1e-16 1 13.5% 6:153 4:152 -----FNRLSLRERILVLIALPLVILFAGYRFGWVPLSEARTAARVEIQGYQTLIEAAENQGNqvEVATVAVVTTPLATRITDSAARAQVLVRRLEPEGALVRVTLDDAPYDAVIKWIAAMETDAEIALVAIEMDRRTAPGIVAARLTLENAQ
47 UniRef50_A3WP21 Type II secretory pathway, ... 87 1e-16 1 11.9% 3:153 21:175 --QQRWAQLAVREQNLVKGLGAVIIVAIIYFAIWQPTYSAQQLAERRLEGQQQQLLWLREQVARYQSlaQSEVSGSLSQRVNEAAASNKIQIARMQPQNNGLIVSVDETSYQQAMSWLYALEQTYQLQVTTLDLARLDELGKVRVRQVLVTEK
48 UniRef50_C4L989 General secretion pathway M... 87 2e-16 1 19.6% 2:149 1:153 -MKQWWQDRTTRERRIVLAAALVLLSIILYWNVWSPLQQHLQQQRGQVQQLQQQLSWMQQQAPLVRQLKQQSASpdIASTLSNSSQGYQIVLKRIQPQGTNALVEMDTTSFEQLVSWLNMLEQQYGITPQQIDLQPAEVPGKAQVRRLL----
49 UniRef50_Q31J18 Type II secretion pathway p... 85 9e-16 1 12.2% 6:153 14:167 -----WKGFSQRDQRAIMILGGVLLCAVLYFLIWLPSEHAKQQAQQKLALSQQKWDWLNEQLPKVAQRGPVLPASTLkqFIQAQLRQLNltIERIETQGHKVVVEFKEVNAPRLFRWLSQ-QEQQGLIAYSADLKPLQ-PGIVTAKVIFEVSK
50 UniRef50_C7R8F1 General secretion pathway M... 83 3e-15 1 14.2% 2:149 4:156 -IKTLYSGLQKREQNMVLALGIAMTILLVFLLVVLPLKSYFDNLNDDLSYYESQMVTVQKQVAAIKSAGPAKanVSLNQLVNQSAKSFGLSFSRIeeRNKEIQLRLDDVEFDQLLRWISLLEQERGLVVDTLRVSKKDTVGKVDASIKL----
51 UniRef50_B7UZ45 Probable type II secretion ... 83 3e-15 1 14.4% 2:140 25:165 -LQAYWRQLAPRERKILAGGGLALCLALTWQVFIDPPLARIEHWQAELPRLRAQAAAVDGVLREVEALRGPTLSGTADAeiRRSLRDQGLdfQLDAPQPGQWQLDFASVSGEALLRWLARSPAALRLSVSEAQVTRLDAP-------------
52 UniRef50_B3R7X0 GENERAL SECRETORY PATHWAY M... 82 4e-15 1 16.8% 2:150 45:198 -FDAFWSARNPREQAILAGGAAVLALVLGYLLLWEPAADGRDRAARNLPQLRADLAEMETLAQEARGLKATPagDELTQALQESLGQYGLKATRlaAADNSVQVQLDKVPFGAVSTWLQDVRQQQRMKVIDARVVYVGATALVNVTATLQ---
53 UniRef50_A1U0C6 General secretion pathway M... 82 5e-15 1 15.5% 2:149 14:175 -LIARYDQLPTRDRQALTALGIALLLALIYLLIWQPVTQFHDRAASSRENAAELLAWMRANETTIQRLgkPEDGRALMALVTRSAGEAGLSLQRFEPSGEgiRVWLENAAYADVAAWLERLHSNHGVVIDQAALDRGNGPGQVSVRLTL----
54 UniRef50_Q1IB25 Putative type II secretion ... 82 6e-15 1 15.2% 3:153 15:160 --RQRWQALAPRERRAVALAGAVLGSFFCWQVLVAPALTRIEHWNTETPKLRSQAQALDALLGQ--------RSADLAGALAQSLDEAGLRasQLDAEGDGWHLAWRQAPAEPAMAWLQRIPPRLGLTIGQLSLRRDPGAGtvTFSGTLRMDQ
55 UniRef50_A0Z781 Putative uncharacterized pr... 82 8e-15 1 12.1% 1:149 1:153 MLGDWFNARPRREQLYLLSMILAVGVWVVVQVIILPASAARQQMEINNQRASEVLTRVDAKATRLVALRSAAQssSLTAAISRISKLEGLVVRRLQPNsgEVQVRFEAINYDALVKWLYRLEVTEGLLVIDVAIVRSSGAGGVNATIRV----
56 UniRef50_A3UEX1 Putative uncharacterized pr... 80 1e-14 1 19.7% 6:152 14:164 -----FQARTAREQALLAGLAVLVVLTIAWFGVLAPAMSWRADAARRYANAAEGYESILVQASEYRALSAQAVNapLRTLADRTARERGLAISRVQpeDGRLGVWMEQADADSLMGWLSLLSREHGVNAERVSLDREGET-RVRAQLTLVRA-
57 UniRef50_Q0C118 General secretion pathway p... 80 2e-14 1 11.3% 2:142 1:151 -MTGWWNTRTPREKMLLAIAGFILAVAVIWQLVLNPAIHTLERAKRSHEQSAQTLARLDRIESLMQqaPSTQDTAALLSEAERMAREGNLLLSGSEPAssSFRVKLSAVSGPAFFQWVEQVETGLGVSVSAASLTQNADGSM-----------
58 UniRef50_A4VFT9 General secretion pathway p... 80 2e-14 1 17.6% 4:151 18:168 ---QRWQRLAPRERTSLSLLGAFLLAVLFYLWLWLPAQRQAAEARDYYQAQRELHAYMEQNTELARQMERSNqpEQLQGVITESAQQGNLSIESFDNGSDglQVSLPGASYALLLRWFDTL-QGQGVSVTEVSLERAGE-GLVNARVSFRA--
59 UniRef50_B8L5U1 General secretion pathway p... 79 6e-14 1 13.6% 2:148 15:162 -LQQRWQRLPPRDRLMLGVMMGALLVAGLWSFWLEPLLKQRTHWQAELPRLQAQANALAPLLRARERQQQARDQRPTLAGLRERIRSAGLAEGliEARDGRWHLRVQGVPADALWNWLLPVLADPAIELQQLQLTRTGDANMPAARIS-----
60 UniRef50_Q2Y7T4 General secretion pathway M... 79 6e-14 1 14.6% 2:152 5:160 -LRKAWESRSPRERRVITILGMIL-SAGLYLGLVSSADRARTRLRSNLPQLRVQAEEFEQQAAEYERIKVTPSPPPLSGDLHALAQTQADILGLSHagDDQVQVTFKAVPFADWLKW-TVAMQLQRVRFEKGRIEALPEPGIVTVTGTFVRA-
61 UniRef50_A5V9H7 General secretion pathway M... 79 7e-14 1 16.4% 6:151 24:168 -----WQARSRREQWLLGGLAAMVALYVLVAMVILPVQRARAQALSDIRTYESLSARLRSAGPLGQAPAQPQAGGSPAAVLSASAARFGMVPV-VNEGGEGIRVTVADAPYESLLRWIAEVEQTSRLRVVRLRLDRRPSSGFVSAELMVRA--
62 UniRef50_Q0ASQ4 General secretion pathway M... 77 2e-13 1 17.8% 4:149 10:160 ---AWWDGLSSREQVMMAVLGALAMILLVSLLIIQPLLGAHDRARDSYAASMRLYRAVEADADTVqaPASTAPAQSLRAVAGSMALRHDIALARMVpeDGRLTVNIDRAETAAILAWLVDLDRRYGIRAQASTLDR-DADGFVSASFVL----
63 UniRef50_Q2G4Y9 Putative uncharacterized pr... 77 2e-13 1 14.6% 2:152 5:157 -LNVWYGGLTARERGLVSVAGGLVASIVLVYGIVLPVGTALDDAADRHRNATERAGRIEAQIAALKAAPaaVLAGPVEQIAGASAQEAGFVVQSNQRRGSDMAvlIPTARPSAALAWLDGLMA-QGLAVEQLTMTPAPD-GSVSVNVTLRRS-
64 UniRef50_Q5QY94 Type II secretory pathway, ... 76 3e-13 1 10.0% 3:152 16:170 --KQRWQQFNQREQSLLAVLAGVLFIAFLYFVIWQPSSQAVANAERQLAAQQQQYQWVQQAIARYKKleQQSASGSVSQRINRAAAAQDIQIARLQPQGQEYLLSVDEVAFSDLLSFLAELEQRQGLSLKAVDIAKLNTPGQVRLRKLLVSE-
65 UniRef50_B8KQL9 Putative uncharacterized pr... 74 1e-12 1 12.6% 2:152 1:155 -MKTWFRQLPQRDQIALLLLAGALSLWLVYQALLMPAKTQRERLLATNDAAAQLLGRVDTKVSqlREQGGSRRSQNITATINSTTRALGIAVQRMQPNsgEVQIRMEDVDYDLLVRWLHRIEVVEGLLIVEASIAQSGRSGSVNASIRIAQS-
66 UniRef50_A3VSL0 Putative uncharacterized pr... 74 2e-12 1 15.5% 2:149 1:147 -MTEFWYARSVREQRIILAGAGALLLLIFVLLVVQPLIDYRRTAIADHQRAMDTYLAVTRAVSRASAGPVREPSV-LRSTIDRVARERQIVLTRTAIDEDAVVVSTGGVTTATLMNWLDTLRDEHHIAVRDAQIRPASAGNGVTARLTL----
67 UniRef50_A3YCB4 General secretion pathway p... 74 2e-12 1 14.4% 4:149 19:170 ---QKYQALSKREQKLVACLAFVLFIYLLYSLLWVPIHQQKEVAQKRVDANLKSYYLLVENAPLLTKSLGDssGQALQALVSRTMRKQKLVAQRMNLDGdrLQVWVENTSYSDINKWMTILAKEK-VSIYSVQF-ASRELGVVDMRLTL----
68 UniRef50_C3KC63 Putative general secretory ... 73 3e-12 1 20.3% 6:153 38:187 -----WRGLSRREKRMVAGTALLLVGLLSWLVLIQPALKKIEYWQAETPKLRAQTEALERL---LREVPTPTAGQPLEPALRQSLDARGLvyYQLTPVETGWQLTFETAPADAVIGWLVSNPRQFSLEVVEARLQRAgdDTAGTLSGTVRMDQ
69 UniRef50_Q48JN4 General secretion pathway p... 73 3e-12 1 15.0% 7:153 21:175 ------AGLSIRETRLLSIGALVLCCLVTWLLMVQPALKKITYWQAQNPVLSAQAETLETLLKQVRVPQRRTGPQDLQPALQRSLEAFGlsYCQLEQDGerWQLAFDHAPADAVIGWLLEQPQLFSLHIKDASLQRAGEDAqgHLSGVVRMDQ
70 UniRef50_D0KWL7 General secretion pathway M... 72 6e-12 1 10.8% 2:149 8:165 -FSSFWQQRNQSERRTLTLAAIALVALVGYQFVWSPMQQAVQRAHDRLAQAEQLaaQAKKALMQAGPKSAQPSADSPMLWVEQAARTVGIEQQLVQRqdDRVQLKFAAVPFDLLLRWLAQ-ANDAGLSVQSANITpsDAAGLVDAEITL----
71 UniRef50_Q6LM86 Hypothetical MSHA biogenesi... 71 8e-12 1 6.6% 2:137 7:137 -LSDRFDLLTRREQILILVSGWVALLFVGFVVVIEPTMKDVTSIKRQLVSAANELVSSDNQIAAINRKLNSDPNNDVDKKIERLEQQ---TDGLNEQLTDRVASLVTPIQMSGLME--EVLRRTTRLKLISLESQAP----------------
72 UniRef50_Q8KTJ4 GspM (Fragment) n=1 Tax=Bur... 71 1e-11 1 12.9% 19:150 1:137 ------------------WGGAVLAVLIGYSVLWSPAQEGRARIQKKLPTLPHELANMTAQAHQGKSLPPPAQGValKNALTGSLSDHGFKGAQGQGVGGGVQVQMKNVSFPAWTQWLDDARRQFKGQVGEAHATALKDDGQVDLTAVMQ---
73 UniRef50_Q1GWC5 Putative uncharacterized pr... 70 3e-11 1 18.8% 2:150 5:156 -LKYWWAGLSGRERWLVGI-AAVLALGVLGWGLGRPAVAAFIDLENRHRAAIEREGRVAAKVALLGARPqsADAGAIDQFLQQSAGEIGLTLDRNEARgnRAAIAIATAKAPVLTDWLASLEA-QGFVIDQLTITPA-ADGTVGMTAELR---
74 UniRef50_D0I544 MSHA biogenesis protein Msh... 69 3e-11 1 8.3% 2:133 8:134 -VKGAFEALSSREQWMIAIAGWIAILGLGVAVFIEPQGNALAQLDAQIMQSEHTTQDLQALNRLKQEKLQSSPNTELEAELERLNQTLSSLDSEIARKVDGL---VSAAQMSALME--SVLRQSDRLTLMSMR--------------------
75 UniRef50_Q3AED7 Putative uncharacterized pr... 69 4e-11 1 12.2% 5:152 3:177 ----FWEKLAPRERILVGIALGLTVFYLLYYYAIMPNWQKYQELKTELNTVNAEWERLqeNVLATEVKNKEQLEKELKNilLASAKEKNIRLLEFKPGSveFPVEIKVQgyPQVLEYVESLENFPDleIKNLTISSVPGDVRGNVEAAFTLA-
76 UniRef50_B8GXS2 Type II secretion pathway p... 69 4e-11 1 16.3% 3:149 9:153 --RLWWTGRTGREQVLLAVMVAALVVVIGWYGVATPLWSAAKTAQVRVDKAATQLATLRGLAA--GASRATAGGAAPQAVVEAAASRVGLPIArrQDANGRFTIWIAAIDSKILLPWTAGLEREGAVKVTDFTASRLDN-GLIEAEITF----
77 UniRef50_Q8GBD7 Yts1M protein n=2 Tax=Yersi... 69 5e-11 1 21.7% 2:153 4:157 -IKQRWQNYSKREQLIFSLGGLVLLGLIVSQGIVAPLENYQHQSTQNLHSAQRDFAALLQQQERISRLQAQRPPqsADRALHESAHQKNMTITLLEANANRAVVAPLTLPFSQLLSWLEQLEAQYGLQASQLKLV-ADVDNLSRVHITTLVLQ
78 UniRef50_A8ZWZ2 Putative uncharacterized pr... 69 7e-11 1 12.1% 4:152 11:180 ---TFFRGLTPRERYAVCIGVAAVLLLFFWKGVAAPLSDKRETLVVQLASRQNDLKQmqAAARAAAGQSGRGADFTLFSFLDRLAGRAGIkiAYMRPSVSgvEMKLEGVDLQGLVSYLHMIETADAMvvTRLSIAAQEKGGGGGVEAVLRVE-
79 UniRef50_Q7MHC2 MSHA biogenesis protein Msh... 68 8e-11 1 14.6% 2:138 1:139 -MKQQWNalSGREKWLITLCGLVVIVLLLFTLVIEPAWKQLAAKKEQLSSTIQLNQKLQGDILVIQAKLNKDPNREIDIEMKslARSQELGMQLSEVIGNLLS----PSQMAELLE--TVLDKSSGVKLISLESLRAE---------------
80 UniRef50_C6P582 General secretion pathway M... 68 9e-11 1 14.4% 6:151 13:163 -----WDVLGATEQKTVIRGAWILLPLLMYGLLWQPAHQALPKLQTALPQLRAQAAQMQSLAGQVQSLRQQadSDALKIAVEKAASEANLPLQIVPGEPNSVRISADSIAFAQWLQWQRSLEQTHHIRVSSAMLVATTETGMVKVQATLTN--
81 UniRef50_B8FE39 Putative uncharacterized pr... 68 1e-10 1 12.4% 7:151 2:169 ------NRLGNREKLILAAGIFVAFAILVHAFIITPALEGSRKRQAELRKMESNLVSIMELAEEYKKAKMNTndFSLDNYLGQLARQAGvsSKKPIANSDFVqiKLDDVTTEELLNYLHKIETSPnlSVRRITVTRSQREDDYGVSATFQV--
82 UniRef50_Q15ZI8 MSHA biogenesis protein Msh... 67 1e-10 1 9.7% 4:137 14:142 ---AQFLAITQREQILILLSGVVVIGMVGYLLFIEPVNETVTRDEQNIASMRNQVRSVEAQIEVSEHAFSNDPNEQLVASLN------KLKQRSLDLDTDLQQETVNLVPPKQMPLLLEklAESQGVTLISMQSIPP----------------
83 UniRef50_Q1K1Y8 Putative uncharacterized pr... 66 3e-10 1 11.6% 2:139 11:143 -VKGWFAALNKREQRLIVGTLFGAPLFVFIQLIFLPGLTEQTALERQVHQLEQDNTILQSQVLEMSLLAEKDPDADNRKKLEQLQQEIARFDQRLQENLSGL---VAPAQMPGLLR--SMLKQRAGLTLISMENAQPQA--------------
84 UniRef50_Q2BKX2 MSHA biogenesis protein Msh... 66 3e-10 1 11.5% 3:132 9:133 --SAKWQGFSPRERILLLFTAVVAPVVLIFIFLLEPALITLQKTPAKIETLQTEINSQQRVLDLLRGQQVKDPNVAARAELK------KLRTQLSDVNNEIRRAATNLVTPDQMLSMLHslADDQGIKLVSA---------------------
85 UniRef50_A1WTW3 MSHA biogenesis protein Msh... 66 4e-10 1 10.5% 2:144 10:147 -LNDALNARTPRERVLMVIAGLGVIGAGWYYLLFEPMQQRSADAQQRIESAEQQIRDLRTQRESLEAELGDDPEADVRAELDALRDEL---LALERDVGERVPEFIEPERMRQVLR--AVLAEHQGARLVRLERLPAQEVAGVE---------
86 UniRef50_A1TKM9 Putative uncharacterized pr... 64 1e-09 1 14.2% 1:141 19:161 VLRARWKTLAPREQSLVLAAGTVVAVALLWWVALAPALRTLREAPAQHAALDAQLQRMQALQSeqLQAAPAAPAGDASQVLRTSLAQRLGSQAQISILGDRATVTLKAAPADGVAEWLSQARSNARAVPVEARLARSTAAA------------
87 UniRef50_Q1YQU6 Putative uncharacterized pr... 64 2e-09 1 12.9% 2:140 10:152 -ISAWLSQRQPRERIIVVVGAGIVFVVAVYLALL-PSLERSTELQERHRILQADLHWLSEQSDSVSRLSNSCVDKTikDVINRLVRRNQIKLVKIAEQAQgyALSLESINANRLLQFAHQLA-CQGLKTNLLDVSRSDAT-------------
88 UniRef50_A5F8T2 MSHA biogenesis protein Msh... 64 2e-09 1 12.4% 2:138 8:139 -FESRFSALSQREKVLITLCGSVLIVMMLLLGLIEPALKQGQARQLQMQTLTSSNLQLQGEIMALQAQLAKNPDQELDVELSQLTLQSQEISELLAAKMTSM---VAPSEMPNLLE--SVLKQGQQLKLVSLESLPAE---------------
89 UniRef50_Q47HN4 Putative uncharacterized pr... 63 3e-09 1 9.0% 2:145 11:150 -LNKRYSSLAKRERQLVAVALILGPLLIGNALFVDPLRARLNGTENTIATESASAAQLQAEAANLQQQLAIDPDAGRKAELAALSGERDKLDEQLRQLGSAL---VRPEEMNALLERL--LARHPGLRLLSltLAPQSALGRVDV--------
90 UniRef50_C6CIM7 Putative uncharacterized pr... 63 3e-09 1 15.0% 6:145 8:141 -----WRAFTRAQRRWLAAMGAIVIL----------LSALLVHVGEKSAQLHQASVWVAQQQDFTVWLAARPdaLPLQEALRRSAPPAALAAVFQYHPREAVLASPAAVGFNALFLWLSDLQQQYGISVVQLDVVPANEPGDIRL--------
91 UniRef50_A3W189 Putative uncharacterized pr... 63 3e-09 1 17.8% 2:153 8:171 -LTGFLLGLSRRERWLVALLGLIALPLAAVYGIALPLADSRETARAAVAEARATELWVADQAVQFATLARDAGNGPKVAriEASLRDAGLrsQLANAADGGITLRFDAVRFTQLAEWLTSQNDIWGYDLAGFTFERGARTDVVAADLRLVAVQ
92 UniRef50_D0Z1S9 MSHA biogenesis protein Msh... 62 5e-09 1 9.1% 2:133 7:133 -LDQKFAALSLREKWLITGCGFVAIFFVGIFTFIQPLMADADSAHLSTLDVKNQVITANNQVIVLNNKLKEDPD-----------AKINVNIAKLQHQETQLKLELdpQQMPALLE--HVLQQSASLHLVSME--------------------
93 UniRef50_C8PZS1 Putative uncharacterized pr... 62 5e-09 1 13.1% 6:142 22:154 -----FQNLSRRDQIALLILAMFLLFFVVGVGGWT-LHSKANLAQKKYDDTMVDVFWLRSQAGNIN--PNQTQQVNQADAIKQILSQSGIVNAQVVENGNTIQVAFSHAQASVITNIFNQFEQ-QGIRIQQLQINQPALDKL-----------
94 UniRef50_A6GLQ0 Probable type II secretion ... 62 6e-09 1 9.4% 3:140 11:155 --QAQLDQLNSRERKLVTYGGALAAVLIAWFVLIEPALLTIQQGPANQAALVDKAGQVMRAAQDLEALRGArpESDLQARLQQLLEEQGVSEqlVRTEEGDIRVEFNNVSASGFLAWMARAEAISSISLNLAEVEKVEAG-------------
95 UniRef50_Q2S973 Putative uncharacterized pr... 62 7e-09 1 9.8% 1:132 1:130 MMKKWISRVNrrERGILLATVVVALILLYAQFAWEPLWRSNRSAEQAIAAANLELVDLSAQTDVLRKQLAQDPDAALRKENERLRNQLNARQERLKQNLSRL---VAPEEMPELL--MALLHKHPGLQVVAV---------------------
96 UniRef50_B9TJM6 Putative uncharacterized pr... 61 9e-09 1 14.9% 38:151 1:117 -------------------------------------MDGAAQLHKELPQLHQQAAEMQVMAREAQALQGqaPSPMTREMLNAGLSARGLTPQSLNVTGEYAKLQFNGAQYAGIVAWLDAIRTESRINVVDASFTAQDAPGVVNGTLTLRQ--
97 UniRef50_B1Y327 General secretion pathway M... 61 1e-08 1 13.5% 2:149 18:166 -LAQRWQALAPRERTGASLAIAALTLLLVWSVAIQPALRTLRTVPAQRAELDAQLARMQALAQEARELRALPPVAPEQSENarGATTRLGAGARLNLSGDRATVTLNAVDPAALTAWLAEVRSAARARVVELQLNRSGAGYSGTVVLTL----
98 UniRef50_P25061 General secretion pathway p... 61 1e-08 1 12.6% 2:152 20:174 -LAIRWRGLPARDRLALLWLGAFLLLVVLYLALWRPAERHLQSARQYFTEQRALHAYIQQQAPNVRQADAAadPAALQGMVTASAAQAGLSVERLDNEGEgvQVALQPAPFAKLLPWLEQL-NGQGVQVAEAGLDR-QVDGRVSARLSLRVE-
99 UniRef50_D0LLX2 Putative uncharacterized pr... 60 2e-08 1 13.3% 2:136 8:158 -LRDRWEQISPREQRMILVLGITFVVVVLALlgISGGLGAIEERNEQVRTALRSLGDYREHLAKGGGTPgpDEPVKLQSYLEGVATEVGITIPGFKPQTGSarIEVNGLSLSQLTAFLERVESKSpvMVEQLDIKR-----------------
100 UniRef50_C5BR21 MSHA biogenesis protein, Ms... 60 2e-08 1 9.5% 3:139 14:145 --QAQFSKLSFRERILAGAGVFGLLLMAWHFAFLAPAISEQERLQQRFEQAQKELKSLGMEEQALVSAMSSDPSLVLRKRVDNLQAELNALDQHVQQMSAGL---ISAQRLPELLQ--AILKETSGLELVAMRIAAPQK--------------
101 UniRef50_C6N6C3 Putative MSHA biogenesis pr... 60 3e-08 1 18.2% 2:138 14:145 -LKQKITHLSERDKVLLLFITVIILFTFWFLVIWEPQTNSINELNQKTEKVQGQIDALTQKKMIISILISNPNTAGifNELTTKLAKLNKEITRYNER------YISSRNLAKLLH--DMLKQTLGVTIDDFSTVPPP---------------
102 UniRef50_A3ERG7 Putative uncharacterized pr... 59 4e-08 1 13.2% 2:153 19:194 -IKLRWEQLSRREKRLLSVLGTILALYLLQvfLMTPYQQYRDelRSDIFQALALSREIRQSQEKIRERSRtrGGFSLISYLEQEADRTHIRSSVTqpDGnlVSIRIEKVDLPHILVFLARLErrHLIRITRITLERrdQHRLLDVRIDVQSIQ
103 UniRef50_C6WW12 Putative mannose-sensitive ... 59 7e-08 1 10.8% 1:139 11:144 LLSNKVESLNQRERLMVLGAAALLTYTVMQMLLLDSLETHKKRLLTEISTDQALVQELQQQTALYINKPPIDPDAQNKERIAE------LNTQLQALKSAQSQLDVSLISPEKMPELLRDLLSKNglKLIALNTLPTQN--------------
104 UniRef50_B5FGN4 Msha biogenesis protein msh... 59 7e-08 1 10.4% 2:116 7:118 -VKEKFGALSQREKVLITLVGWVAVIFISLSLFIEPKIEQYHQSQQKVARITNSISSLKQQIELAEFRLKKDPNVEiqQLMIESQDLADLLFSRVASL-------VSPSQMASLLE-------------------------------------
105 UniRef50_A6V156 General secretion pathway p... 56 3e-07 1 12.0% 2:151 8:154 -LHARWLRLPTRERRALLGLAAFLGLSLAWVLLWQPQRQALLDAERHYQDELRLHADLQRLPGDTGGGPRID-ATALPGLLARSSAQARLNVERMDSEGSGRMNLALEGQLADLLGWFESLGRS-GVEVTSLDLEVSPDA-LARARLAVEL--
106 UniRef50_A8GJP6 Putative uncharacterized pr... 56 4e-07 1 20.3% 24:151 15:146 -----------------------AALIFCGMLVAVSLLAFYLQQKGQAQQANAELAQMQRNAQRIVMLRHPleGTSLQTLLKTSAEKLGLRLGTVRSDKNNLDVALPPQPVKPLLLWLENLQQAYGMGVNSIDLSLHGDEVRVQA-LTLQV--
107 UniRef50_Q1D9F1 Putative uncharacterized pr... 56 4e-07 1 8.1% 2:149 11:178 -VQTWFERLSDRERRMVSIAglVFVLFAVVMTFTNSASGYRKRTEEKLTKLQelAASFREAQANRQSVEqrSSNVQLISYIEDKATLAGLQVPNMTPKGeaVELTFTDVDLRKLTDFLQTVESGPgvKVKLLRIEPRPASDTLTAWTTV----
108 UniRef50_B4WDR0 Putative uncharacterized pr... 55 6e-07 1 12.9% 4:142 10:147 ---AWWDGRTLREQRMLTVMGLAIAAVLVWLLIVRPAWAWRADAAEARAVAEADLALVQTATGRMARTDAASSDVDVAAVVAEVGSITGVTPVMGMSPDGGLGFNLTNVSSTAAFGWLAALHDRK-VEATTLNVVENADATI-----------
109 UniRef50_C6BWY4 ABC-type nitrate/sulfonate/... 55 9e-07 1 12.4% 6:94 8:94 -----WNKLDPRDRRALGICLIFLFSVVLYMGVLAPLGNMY---EATVQEQVELKQEIQLNTPKAMVLPDREAkrQVKNEYESLKRQLDLVDRR-----------------------------------------------------------
110 UniRef50_B2A7F6 Putative uncharacterized pr... 55 1e-06 1 15.6% 2:65 8:71 -LINKLSSLSKRERLLLMIAGILVVFVSFWQFIFIPFENRRSELEKNIDHTQQNINHLQGKLSEW----------------------------------------------------------------------------------------
111 UniRef50_Q2KZN1 General secretion pathway p... 54 1e-06 1 15.6% 19:153 39:184 ------------------AVSAILAAAVIFLGFIEPPLAKLARLRTDLPSLRIQAAAVDDLAARASALSRRAqeLPTPSDLRGSLIHAGLPADhlTREDAVYVLTLNDVPAQRLLDWLETSARDWGLLARQAELARapLPGLVNASLRLALTQ
112 UniRef50_B0TEF5 Putative uncharacterized pr... 54 2e-06 1 11.6% 4:98 35:147 ---NWWMARTKRERVLLSLFGAAVAGAGLYLLVLEGQLDQFSTLSTELPVSKQQLESAKRRIQniSAYPAALSSGSMAVLIGEAAKASKVTIKYFVPQ-------------------------------------------------------
113 UniRef50_Q4KD21 Probable type II secretion ... 53 3e-06 1 18.3% 6:131 24:154 -----WNGLALREKRLLGATALGLLGLLLWLLLIQPPLKKIDYWQAETPKLRSQAEALEVLLHEVAAGSRNAPGESLEQALRQALDAAGLQGRYqqAGPESWRLTFEQAPADAVVGWLLGAPRQFSLQVVE----------------------
114 UniRef50_C4ZCH2 Putative uncharacterized pr... 52 4e-06 1 13.2% 9:76 1:68 --------MSTRDKKLLIILAGVAILALTYFLIFMPQSNKRDSLKSENMNLKSQYNQLSALAAKADDYTKKTKDMS-----------------------------------------------------------------------------
115 UniRef50_A7C5U9 Putative uncharacterized pr... 52 5e-06 1 10.5% 75:150 2:80 --------------------------------------------------------------------------QSLLNLIDKSTRIGALRNANKQIEaqEVRVNFEEVSFTDLMRWLGQLYNQHQIQVSTMSIEQKHKPNKVKVRLTLK---
116 UniRef50_B1I3E4 Putative uncharacterized pr... 52 7e-06 1 11.4% 6:93 2:87 -----WQNLSERQRLLVMVAATVLVFALLYLLVLSRQISAFQRAGAALEATSAELQQYRAKAARFEVEKEREAASQIR--LEELSRHFDTNYQ------------------------------------------------------------
117 UniRef50_Q1QBS3 Putative uncharacterized pr... 52 8e-06 1 13.2% 1:152 30:186 LLFVRWQALSSRDQLALLLLSAFLLLFIGGYGGYS-IHQAANHSKSEYQEQVADYFWLRAQAGNIDSNALAAANtpATSSVNALLTNSGIVDAQVIANGNTVQLSFNNPSQAVVSAALGKLEQ-QGWQFTQLSMQQDLLTKAIQVQATVTLS-
118 UniRef50_C6HW27 Putative uncharacterized pr... 51 9e-06 1 15.6% 7:153 30:200 ------ERLTPREKRLVRILLSLVGGIVLWQGVTLVFWDPYQAREAELADLRSETLKVATLAREiqRLAREERGFSLISTLEEEADKAHirITRMTPRtaMVSLEIDSVDLPHALVFLARIQRSPhiRVTRLSMKRrnDHSKIDLSLDVEAVQ
119 UniRef50_B8D2D7 Putative uncharacterized pr... 50 2e-05 1 20.0% 6:55 2:51 -----WHNLSDREKKLIIFGLIAVICMVYWFYGEQPTTRTIDELESDLQQLRREL--------------------------------------------------------------------------------------------------
120 UniRef50_A9GDP3 Putative uncharacterized pr... 50 2e-05 1 9.1% 2:100 3:109 -LRERLDKLEPRERRLLTILLGFLAVIVL-LLVPIGLASVASSKRAENQEIRDLLQSIYEASGKVSERKaaRPAPALAGFIEDAAKQQQLTAAESQDRPD-----------------------------------------------------
121 UniRef50_A9IRQ5 General secretion pathway p... 49 4e-05 1 16.7% 4:141 35:192 ---SWYALRPRREQRLLACAGALLAAALVFLLLVEPAWSTMTRTRQELPDLRAQTATVAELTAQVRALRRRDAGAATAseLTASLRREGLPDseAAAPASAIRLNLREASAAALFRWLDTAARDWRLSVADAELARATNPA------------
122 UniRef50_UPI00016990A6 hypothetical protein Epers_... 47 2e-04 1 14.7% 2:96 1:102 -MIRWFYAKPPRERLALLTGGASLLILLIYLLVWTPFISKLERKQAQLESQRATLAWLQSAVSEVAQLRAAQpnESLFTLVDRTATQNRLRKQIDQ---------------------------------------------------------
123 UniRef50_Q12DW5 Putative uncharacterized pr... 46 3e-04 1 12.4% 2:138 10:147 -LQARWHALGQREQTLLRSVALLVGLALLWWGLMAPPLRTLRQAEAQQRSLDAQWQKMQGLRAQAQAL-QSQPRISRDDALRALQASVKlaSAQLSVVGDRATVTLRNTPADALAQWLAQARANAGAIPDEARLVRNA---------------
124 UniRef50_A7C5V0 Putative uncharacterized pr... 46 3e-04 1 9.5% 4:45 2:43 ---NWFKQLAPHERRTLMIGTIALSSLLFYFLIWEPFVTARTQLE------------------------------------------------------------------------------------------------------------
125 UniRef50_Q21LN4 Putative uncharacterized pr... 55 6e-07 1 8.0% 1:138 4:143 LLQQKwnARNTRERALIAVSCWAMIYLVWDFAFFQPLNKQKEALQQRFDATNQTLVQLDAQQQVFVRALSSDPNAGRRREIVALKESITVLDNEINRLSDGL------IPAPKLPQLLHdlRANNNLKLVSMRTQPAE---------------
126 UniRef50_A0YA33 Hypothetical MSHA biogenesi... 52 5e-06 1 11.1% 3:137 9:138 --KSKFDVLAQRERILLLVCAAVVTIMLMQVVLLDPLLGTSKKISSRAAEASGKISRYQAEKQVVEAQLGVGVEGAKKEQLERLESEL---DDLNEEIEDSVQGMIPPRLMPEVLE--KVLLESQGLKLLSLENQPV----------------
127 UniRef50_B4S2I3 Putative Mannose-sensitive ... 49 5e-05 1 8.0% 2:138 7:138 -LSEKFSALEGREKQLILWVSFGLIVYLFFWFGILPALDDLSTADKAVKRKSSEYNALVIQRDAVQQALSIDYTQRTQQELDSARKALLAIDEELLSLNEGF---VAADRMPELL--MTLLNEENNVRLVNFNVEPTQ---------------
128 UniRef50_Q12IV1 MSHA biogenesis protein Msh... 45 0.001 1 9.4% 2:139 8:139 -LASKFNELSQRERVLVGFASLVLVVFSCFMLL-EPMLLDNQQRAQHLKELHHSNQMASQSIAVYQQGLSLDPDADYKQRLAMLEQQLIFVDAELSEQM------VDMIPADYMPAVLAqlSQVKGLTLLGFSSLPPQA--------------
129 UniRef50_A1TYM9 Putative uncharacterized pr... 44 0.002 1 10.3% 3:138 12:142 --SQWYNDRPIRERVLVLLTVCVLVFVVGWELLVAPAEARKSQLASQLQVASNTRDALLSQQESLDGQLASDPSTELRERLAARENRLSRLNEQIAETTGQL---IAPRDMVVLLR--EMLAAQQGLELDSMELLAPE---------------
130 UniRef50_A6FG32 Glucose-6-phosphate isomera... 43 0.002 1 10.9% 1:137 1:139 MMKQHwrQLSMRERILIVVSLVASVIYVIDSFVLAPNYARHKQLTSQLSSLGQQQRQHGFTLAELQRVLATDPNKVIKLRILRAENTLKKANGKLTDLTADL---INSNQMALVLG--DVLSRAKKVKLIAIESLPV----------------
131 UniRef50_C0QUI9 Putative uncharacterized pr... 43 0.002 1 14.1% 2:100 6:104 -LKAQWAELPEWQKILVIVLFSVLLLYGIYMVMIESKLTEKKNLQDEVQSLQLQVERLKRAARPEIRKKLEEKYVMVQKEIEQLNKQLERLKDIVPPQED-----------------------------------------------------
132 UniRef50_Q1JVU6 Putative uncharacterized pr... 42 0.004 1 16.5% 8:134 4:152 -------QLSPRELAMVLVAAIFVIATVIYLAMIAPYVATMERLDSKIASRQQQLQqiQGQIKSLQRRQASAGDFALFAYVerIAGRENLTSMRPMptEEAVEIKLENVSLGQMLQLLQSFNSAppLQVKALQL-------------------
133 UniRef50_C8R0C1 General secretion pathway M... 42 0.005 1 10.8% 2:149 11:172 -LEARLEGlpPRQRPLLFIGLGLLVPLLVWLLLLAPLGSSRDSLQRDIGAREQELAWMREAAQEVQRYagARPGGSPLAAIDSSAREFGlaMQRVEPGDGG-----------EVrrWLDRLGRGHGIEAVEVVVEPagRAARVNARLTL----
134 UniRef50_C5CPK5 Putative uncharacterized pr... 42 0.007 1 15.8% 2:140 7:149 -LRARWAALELRERRMVAIAAALVVLALLWWVALAPALRTLAAAPADHAQLDAQLQQmqNRAKALQAQPRLNRDDALRALETSVRESLGTNAQLMTASGDgaTITMRATPADAVAQWLAQARGNAHAVPREAHLTRAAAG-------------
135 UniRef50_A4BG91 Putative uncharacterized pr... 42 0.007 1 4.5% 7:138 14:140 ------ERLSRRERILLLVVLFAVILAAAQSTLMLSGLDRHDRVREQITNVRQQTQATRQALLDYQAAINNPQIQALRDNNDDLRTRIEDLEARIANINSQL---MSPERMISLLKEL--LNDYSNLTVTRFEVQPVE---------------
136 UniRef50_Q2LVK9 Hypothetical membrane prote... 42 0.008 1 11.0% 5:150 9:178 ----YWSGLRQRERIVLGGGLICLFLLLLTHFILLPFFEARDKMTRSIARQEKVLQELTELKAQYQSLkrRSPDFTMASHLDRIINeqDFQSTKSQAGEgrTEIKIARVTMDQLIQFLYLAEseYGIWIEQISIAGGpeTGFLSATLALK---
137 UniRef50_A8VRE6 Periplasmic binding protein... 42 0.008 1 9.2% 10:140 84:215 ---------SFRKQSALIGAGIGAVLLILFVVFwqPldQKYNMADGEEVTVDELNPVNEENIPVVPRSYAEYRSDILMGQLPNQAF-YNLGTTRIQQHDGSL-YWVTPIEYDGLFRWIRS-DAAPGFIVVSAE-NPREEP-------------
138 UniRef50_UPI0001979A79 hypothetical protein HcinC1... 42 0.009 1 13.9% 2:138 9:174 -ITQFLSTKTKREKILLFIAIMALCVFIMMEFIYLPLLqqHQQQTNEVQNLQEEIFSLQQSLSHTTTLEPLLNPFTLIPSLINFAKNENLTLNAFHPHPTLNALVIEGseFWQILNLLSFLENLHFVSLESLELSSQE---------------
139 UniRef50_UPI00016990A5 hypothetical protein Epers_... 41 0.012 1 17.1% 106:146 1:41 ---------------------------------------------------------------------------------------------------------MENAAFDAMLRWLGLLQQQYRIQVVSMNIDSKDKPGRINAR-------
140 UniRef50_B8FH98 Pilus assembly protein PilO... 41 0.013 1 16.1% 8:100 20:130 -------QLSRPQRILIFVAAFLVIGALFTFLLFKPYWTQKSELTTKLENKLNEVRVSQAKAAKleSLPKKKEVPELLDRMSLSGKEAGLEWTLFQPRSE-----------------------------------------------------
141 UniRef50_C1I9R4 Type IV pilus assembly prot... 41 0.014 1 11.3% 8:69 2:63 -------NISKREKYLIGILLTVLICFVYYQFIYTKQVGKLATKRAEKNQVEQRYNDVMDNISKLDSKE------------------------------------------------------------------------------------
142 UniRef50_C9YDY7 Putative uncharacterized pr... 40 0.020 1 14.2% 16:149 1:135 ---------------MLTLAAVLVLGTLLWTVGIAPALRTVKAYPAQRGTLDAQLQSMQALQMRAQNlgQPAVDGRAAQAALQSTVASLGTKANLLVIGQQATVTFRGLDAAVLAQWLARARSEARLVPAQAKLSREGSSWSGTVQFNL----
143 UniRef50_B8GLD3 Putative uncharacterized pr... 40 0.021 1 11.4% 14:153 19:155 -------------RRALIWGGLAVALILAGWGLFEAGQnrHSDARGEIRELQRRVASLERTNRELVQRNARLERGQIIEKAAAERLRENLAdtRLQSMDEELTFYRNIVSPENL---------ESGLHIHSFVLEPVGASGEYVFRAVLTQIR
144 UniRef50_D0FPJ4 Conserved uncharacterized p... 40 0.021 1 10.3% 4:139 7:139 ---NFWQRRQPRERWLLVICLISAIAAGLYIAREQ-AMVWQQRAVNHLQQRQLEAQQIQQLESRMQAVLARQPEKNP--GLEQLNRLLPPGLVLSQPSPDLWVAARGTVALGSLLNALVKLEQRYALQPSHLLLEQQGT--------------
145 UniRef50_A3WP68 Type II secretory pathway c... 40 0.026 1 9.5% 11:94 16:100 ----------PRDRrlIAILVWVLIAVYMGSTLLLPNIKAMNSSKLRTEQLAQQLSQVRALNEQLKSQLQQDVNQPIRDDIERKQARLTQLVER-----------------------------------------------------------
146 UniRef50_Q8RAE9 Fimbrial assembly protein n... 39 0.052 1 12.3% 8:153 2:150 -------KLTKREKFLIYFALVFAFFAIYYQFYLIPKLSEIDNLSQEIKLKRQILSQVSSLKGeqKSLAKWEKEVEELNAILPDEKDAEFAILDLQRMASDSGVKIRSINFENASQEEKNKEQKEEFAVTPISVTAFGsdGLISFMKSLQESR
147 UniRef50_Q3A7K1 MshA biogenesis protein, Ms... 39 0.059 1 13.1% 4:133 13:137 ---DWLDQRSLRERVLLAAVVLVVGFLVFDALVFHPQAQNRRHLKTQMATLETTLAELDRQAETVLLRAKEDPDREHRAQQRQLQAELASLDERLKDLTVDL---ISPSDMAEVLREL--LARQQGLRLVHLE--------------------
148 UniRef50_Q670M6 MshJ n=2 Tax=Pseudoalteromo... 38 0.065 1 10.0% 3:102 9:108 --REKFAALQMREKYLIFGVGLFLICYLFGFYLLNPLYLKWQKNAQSLIAIEKKLVANTAQITLFSDALTRDYTQELRSEIATAELALKQVDEKLNQFSQGF---------------------------------------------------
149 UniRef50_C1XGT3 Putative uncharacterized pr... 38 0.076 1 15.2% 11:148 3:121 ----------QREWAIVAIVAALLLGMMWYFFVTQPLQGRIPELQAEVDRLT---------VERDRGRAAQRALPQLRETIARLDAERQQFLRELPP----------TEQLGRVLSSLAQTARESGVVLRALSRSPGDNQGVANVRAT-----
150 UniRef50_Q3SKR0 Putative uncharacterized pr... 38 0.093 1 15.4% 2:79 9:86 -LGERIEGMSPRERAFVFAAAVMLALALVQTLVIDPARERQQRAQERVQSARAALQQIAQQTAAVRDTLRVDPDRTARD--------------------------------------------------------------------------
151 UniRef50_C6P4S8 Putative mannose-sensitive ... 38 0.096 1 8.3% 7:138 15:141 ------DGMSLRERALIFAAAAFLAVSLIDSLFLEPLLDKQKKLSAQVIQQQEKMKETEAQIAALLQAKQADANSPQRERIRVLRQQIADGDAYLKGRRDKL---VPPEKMAQLLE--QVLNRNDRLKLVALNTLPVS---------------
consensus/100% .........................................................................................................................................................
consensus/90% .......h..p-p.hl.hhhhhhhhhhh..hhh.s..t..tt..tt..t..t....h......................h................................h.......................................
consensus/80% ....htths.R-phhlhhhhhhhhhhhhh.hhh.Ph.tthtphptph.t.tt.ht.hpt.h..h.t..t...s..h.t.ltt..tt.th..t..t..tt.h...ht...h.thh.....h....th.h.thp...................
consensus/70% ...hapths.REphhlhhhshhlhhhlhahhlhtPh.pthpphptphtphpppht.hptthtthtth.tttsstsltthlpp.ttphth..tthpststth.h.ht.h.hstlhthlt.lttt.tlpl.thpht..t............
|
MView 1.51.1, Copyright © 1997-2009 Nigel P. Brown